| Date Filed | Type | Description |
| 04/03/2023 |
SC 13G/A
| Palo Alto Investors LP reports a 0% stake in Alimera Sciences, Inc. |
| 02/14/2023 |
SC 13G/A
| Palo Alto Investors LP reports a 11.4% stake in Alimera Sciences, Inc. |
| 02/14/2022 |
SC 13G/A
| Palo Alto Investors LP reports a 5.3% stake in Epizyme, Inc. |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| Palo Alto Investors LP reports a 5.1% stake in Vanda Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G/A
| Palo Alto Investors LP reports a 11.6% stake in Alimera Sciences, Inc. |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| Palo Alto Investors LP reports a 2.4% stake in STAAR Surgical Co |
| 02/14/2022 |
SC 13G/A
| Palo Alto Investors LP reports a 5.1% stake in Insmed Inc. |
| 02/14/2022 |
SC 13G/A
| Palo Alto Investors LP reports a 3.1% stake in Clovis Oncology Inc. |
| 02/14/2022 |
SC 13G/A
| Palo Alto Investors LP reports a 6.1% stake in eHealth, Inc. |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Palo Alto Investors LP reports a 15.6% stake in Alimera Sciences, Inc. |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Palo Alto Investors, LLC reports a 8.5% stake in Vanda Pharmaceuticals, Inc. |
| 02/14/2020 |
SC 13G/A
| Palo Alto Investors, LLC reports a 7.3% stake in Karyopharm Therapeutics Inc. |
| 02/14/2020 |
SC 13G/A
| Palo Alto Investors, LLC reports a 6.8% stake in Epizyme, Inc. |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Palo Alto Investors, LLC reports a 9.2% stake in Clovis Oncology Inc. |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Palo Alto Investors, LLC reports a 16.2% stake in Alimera Sciences, Inc. |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G
| Palo Alto Investors, LLC reports a 5.3% stake in Aimmune Therapeutics, Inc. |
| 02/14/2020 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 02/14/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/19/2019 |
SC 13G/A
| Palo Alto Investors, LLC reports a 8.3% stake in Vanda Pharmaceuticals, Inc. |
| 02/14/2019 |
SC 13G/A
| Palo Alto Investors, LLC reports a 7.9% stake in Vanda Pharmaceuticals, Inc. |
| 02/14/2019 |
SC 13G/A
| Palo Alto Investors, LLC reports a 8.5% stake in STAAR Surgical Company |
|